Charles Homcy
Chairman
BridgeBio Pharma, Inc. (BBIO)Board Member
BridgeBio Pharma, Inc. (BBIO)Board Member
Maze Therapeutics, Inc. (MAZE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles Homcy
Charles Homcy is recorded as Chairman and Board Member at BridgeBio Pharma, Inc. (BBIO) and Board Member at Maze Therapeutics, Inc. (MAZE). The proxy statement of BridgeBio Pharma, Inc. reports total compensation of $1,855,805 for Charles Homcy in fiscal 2020, including a base salary of $500,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BridgeBio Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Neil Kumar CEO, Board Member
- Brian Stephenson CFO
- Thomas Trimarchi CFO, COO
- Brian Stolz COO
- Brian C. Stephenson Chief Accounting Officer
- Ali J. Satvat Board Member
- Andrea Ellis Board Member
- Andrea J. Ellis Board Member
- Andrew W. Lo Board Member
- Douglas A. Dachille Board Member
Leadership on record at Maze Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jason Coloma CEO, Board Member
- Hervé Hoppenot Chairman, Board Member
- Misbah Tahir CFO
- Courtney Phillips General Counsel
- Continuing Directors Board Member
- Daniel Spiegelman Board Member
- Jonathan Lim Board Member
- Nancy C. Andrews, M.D., Ph.D. Board Member
- Neil Kumar Board Member
- Paula A. Johnson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | BridgeBio Pharma, Inc. (BBIO) | Chairman of Pharmaceuticals | $500,000 | $1,855,805 |
| 2019 | BridgeBio Pharma, Inc. (BBIO) | Chairman of Pharmaceuticals | $513,808 | $5,975,842 |
Recent activity
No call appearances or filed executive changes recorded yet.